Right-to-try law intended to weaken FDA, bill’s author tells agency commissioner
The law, which President Trump signed this week, allows patients to receive experimental drugs without FDA oversight.
The law, which President Trump signed this week, allows patients to receive experimental drugs without FDA oversight.